MVision AI

"At MVision AI, we’re shaping a legacy in AI-driven radiotherapy treatment planning. Join us at the forefront of innovation and cancer treatment excellence."

- Dharani Rangaraj, CEO

Our Vision

Our vision is to improve the quality of care for cancer patients, during & after treatment, with the help of collaborative intelligence of humans and AI.

MVision AI Leadership

Dharani Rangaraj

CEO

Jarkko Niemelä

President, Co-Founder

Mahmudul Hasan

Founder & Executive Director

Saad Ullah Akram

CTO, Co-Founder

Stewart Pegrum

VP Global Sales

Gregory Brown

Vice President North American Sales

Anu Savola

Chief Finance Officer

Joona Hartman

VP of Engineering

Kalpana Jha

Head of Regulatory and Compliance

About MVision AI

MVision AI is your trusted partner in healthcare innovation! We are a team of experienced professionals committed to revolutionizing the cancer care industry through the application of cutting-edge AI technology.

At MVision AI, we understand the challenges faced by healthcare providers in delivering accurate, timely, and efficient cancer care to patients. That’s why we are developing a suite of AI-powered solutions that can help streamline workflows, enable treatment quality and facilitate more patient-focused care.

Our AI-powered GBS solution saves treatment planning time and therefore can help clinicians to concentrate on personalized treatment plans for each patient, taking into account their unique anatomy and medical history. This can lead to improved treatment outcomes, reduced side effects, and shorter treatment times.

At MVision AI, we are committed to advancing the field of healthcare through the power of AI. Join us on our mission to transform the industry and improve patient care. Contact us today to learn more about our solutions and how we can help you achieve your healthcare goals.

Testimonials

Hear what people say about us.

“The accuracy of organ-at-risk (OAR) contouring can significantly influence cancer treatment planning. Contour+, powered by AI, not only assists us in contouring these critical organs to protect them but also enables us to achieve much greater precision while saving time“

Dr. Jean Christophe FaivreHead of Radiation Therapy Department, Institut de Cancérologie de Lorraine (Nancy), France

“We have a great improvement of our clinical workflow. We have gained one day just using MVision AI, we don’t need anymore staff, it was four hours of work to contour, now it is ten minutes.”

Marc PachoudHead of Radiotherapy Department, Riviera Chablais Hospital, Switzerland

“MVision AI is assisting our dosimetrists with the field placement, it has reduced some of the variations in our workflow. We only have one match plane position which has greatly simplified things. We have predominantly eliminated this field valuation task for the clinicians and not only does that save clinicians time but that was something that often was a delaying item in the process, so there is a sense that this could speed things up.”

Samantha WarrenMedical Physics, Northern Cancer Centre, UK

"We have imaged and treated our prostate cancer patients during the same day with the help of MVisionAI’s auto-segmentation. Now we can schedule for shorter waiting times with more confidence."

Timo KiljunenAdjunct Professor and Medical Physicist, Docrates Cancer Center, Helsinki

"We have been using MVision AI's autosegmentation software at the Oulu University Hospital since 2019 to all of our curative patients. We are happy to say that the quality of the segmentations is overall at a very good level and only minor adjustments have sometimes been needed to fit them in the clinical workflow. Software has lot of properties the competitors are not able to provide."

Juha NikkinenProfessor, Chief Physicist at Oulu University Hospital, Department of Oncology and Radiotherapy